Affidea Sp. z o.o
Affidea Sp. z o.o is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate Dostarlimab as Sequential Therapy after Chemoradiation in Participants with Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma (JADE)
Sponsor Glaxosmithkline Research & Development Limited
- Start (EU)
- Latest update
- Estimated end
Randomized, double-blind, placebo-controlled trial of the efficacy and safety of tianeptine in the treatment of covid fog symptoms in patients after COVID-19 with the study of the pathophysiology of the phenomenon using positron emission tomography, biochemical, immunological and electrophysiological parameters (COVMENT).
Sponsor Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Affidea Sp. z o.o?
The 2026-10-09 snapshot links Affidea Sp. z o.o to 2 distinct CTIS trials. Recorded services include Imaging tests performing, Medical image analysis- PET CT, PET and/or Bone scan. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Affidea Sp. z o.o?
The most frequently recorded therapeutic areas are Otolaryngology, Solid Tumor Oncology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Affidea Sp. z o.o conducted?
The linked trials record locations in 13 countries, including Poland, Belgium, Czechia, Germany, Spain. These are trial locations, not confirmed office locations or countries where Affidea Sp. z o.o delivered services.
What can this page tell me about Affidea Sp. z o.o's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Affidea Sp. z o.o. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Affidea Sp. z o.o.